Evidence map›Paper›PMID 38843332›Full record

ArticleScience (New York, N.Y.)2024

A master regulator of opioid reward in the ventral prefrontal cortex.

Alexander C W Smith, Soham Ghoshal, Samuel W Centanni, Mary P Heyer, Alberto Corona, Lauren Wills, Emma Andraka, Ye Lei, Richard M O'Connor, Stephanie P B Caligiuri and 7 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Leveraging single-cell spatial transcriptomics and connectomics to resolve brain circuit function in psychiatry.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. A Comprehensive 4-layeredCurrent pharmaceutical biotechnology · 2025
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alexander C W SmithNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0001-7724-6234
Soham GhoshalNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0001-9078-8978
Samuel W CentanniDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.ORCID 0000-0002-3941-7677
Mary P HeyerNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0009-0005-0144-5030
Alberto CoronaNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-2258-1905
Lauren WillsNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-5018-7315
Emma AndrakaNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-3013-2384
Ye LeiNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0009-0004-2204-9320
Richard M O'ConnorNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Stephanie P B CaligiuriNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0001-7906-1831
Sohail KhanNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Kristin BeaumontDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0003-3075-9977
Robert P SebraDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0001-9267-2426
Brigitte L KiefferDouglas Research Center, Department of Psychiatry, McGill University, Montréal, Quebec, Canada.
Danny G WinderDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Masago IshikawaNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Paul J KennyNash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0003-2426-3641

Funding

Transcription Factors in Stimulant and Opioid ActionP01DA047233 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Paul J. Kenny · 2019 to 2026
$16.5M
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional miceU01DA053629 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KENNY, PAUL J., VOLSKY, DAVID J · 2021 to 2025
$11.1M
Development of novel therapeutics for opioid dependenceUH3DA048385 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KAMENECKA, THEODORE M, KENNY, PAUL J. · 2020 to 2022
$5.9M
Sex Dependent Recruitment of PKCdelta Neurons by Stress: Administrative Supplement for Noradrenergic Regulation in the BNSTR01DA042475 · NIDA · VANDERBILT UNIVERSITY · PI WINDER, DANNY G. · 2016 to 2025
$4.0M
Training Program in NeuroscienceT32MH087004 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GEORGE W. HUNTLEY · 2009 to 2026
$4.0M
Training Program in Substance Use DisordersT32DA053558 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Paul J. Kenny · 2021 to 2026
$2.6M
Discovery of novel pharmacotherapeutic targets for opioid addictionR00DA048119 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SMITH, ALEXANDER WANLESS · 2022 to 2024
$747k
Discovery of novel pharmacotherapeutic targets for opioid addictionK99DA048119 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SMITH, ALEXANDER WANLESS · 2020 to 2021
$343k
NIDA NIH HHS K99 DA048119NIDA NIH HHS P01 DA047233NIDA NIH HHS R00 DA048119NIDA NIH HHS R01 DA042475NIDA NIH HHS T32 DA053558NIDA NIH HHS U01 DA053629NIDA NIH HHS UH3 DA048385NIMH NIH HHS T32 MH087004
6 · The paper itself

Abstract

In addition to their intrinsic rewarding properties, opioids can also evoke aversive reactions that protect against misuse. Cellular mechanisms that govern the interplay between opioid reward and aversion are poorly understood. We used whole-brain activity mapping in mice to show that neurons in the dorsal peduncular nucleus (DPn) are highly responsive to the opioid oxycodone. Connectomic profiling revealed that DPn neurons innervate the parabrachial nucleus (PBn). Spatial and single-nuclei transcriptomics resolved a population of PBn-projecting pyramidal neurons in the DPn that express μ-opioid receptors (μORs). Disrupting μOR signaling in the DPn switched oxycodone from rewarding to aversive and exacerbated the severity of opioid withdrawal. These findings identify the DPn as a key substrate for the abuse liability of opioids.

Indexed as

Analgesics, OpioidAvoidance LearningOpioid-Related DisordersOxycodoneParabrachial NucleusPrefrontal CortexReceptors, Opioid, muRewardAnimalsConnectomeMaleMiceMice, Inbred C57BLNeuronsPyramidal CellsSubstance Withdrawal SyndromeAnalgesics, OpioidOprm protein, mouseOxycodoneReceptors, Opioid, mu

Identifiers

PMID38843332
PMCPMC11323237

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.